title: Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
abstract: National guidelines for treatment of ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, and hyponatremia have been approved by the Danish Society of Gastroenterology and Hepatology. Ascites develops in approximately 60% of patients with cirrhosis during a 10 year period and is frequently associated with complications that determine the course of the disease and the prognosis. These evidence-based guidelines are divided in two parts and consider definitions, pathophysiology, diagnostic aspects, treatment, and prophylaxis.
authors.affiliation: Department of Functional Imaging and Research, Section of Clinical Physiology and Nuclear Medicine, Hvidovre Hospital, Denmark.
authors.forename: Søren
authors.initials: S
authors.lastname: Møller
authors.forename: Niels Kristian
authors.initials: NK
authors.lastname: Aagaard
authors.forename: Lars
authors.initials: L
authors.lastname: Schmidt
authors.forename: Henning
authors.initials: H
authors.lastname: Grønbaek
authors.forename: Jesper Bach
authors.initials: JB
authors.lastname: Hansen
authors.forename: Flemming
authors.initials: F
authors.lastname: Bendtsen
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology / Q000503:physiopathology; D002985:Clinical Protocols / Q000592:standards; D000075202:Contraindications; D004232:Diuretics / Q000008:administration & dosage / Q000009:adverse effects; D019317:Evidence-Based Medicine / Q000592:standards; D005440:Fluid Therapy / Q000009:adverse effects / Q000379:methods / Q000592:standards; D006530:Hepatorenal Syndrome / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007010:Hyponatremia / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D008103:Liver Cirrhosis / Q000150:complications / Q000503:physiopathology; D008236:Lypressin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D051436:Renal Insufficiency, Chronic / Q000209:etiology / Q000503:physiopathology; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects; D014883:Water-Electrolyte Imbalance / Q000209:etiology / Q000503:physiopathology
chemical_list: D004232:Diuretics; D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin